Martin R. Berger
- Oncology top 1%
- Metal complexes synthesis and properties 15
- Colorectal Cancer Treatments and Studies 15
- Chemokine receptors and signaling 14
- Cancer Research top 2%
- Immunology top 5%
- Toxin Mechanisms and Immunotoxins 14
- Molecular Biology top 5%
- Cancer therapeutics and mechanisms 14
- PI3K/AKT/mTOR signaling in cancer 13
- Biotechnology top 2%
-
- Bone and Dental Protein Studies 18
-
- Genetic factors in colorectal cancer 13
- Co-authors
- Hassan AdwanD. SchmählSpiro KonstantinovTobias BäuerleCarl C. SchimanskiMichael ZeppPeter R. GalleBernhard K. Keppler
- Cited by
- OncologyCancer ResearchImmunology
- Journals
- Journal of Cancer Research and Clinical Oncology (31 papers)Cancer Letters (14 papers)International Journal of Cancer (9 papers)
- Partner nations
- GermanyBulgariaUnited States
In The Last Decade
Martin R. Berger
241 papers receiving 4.7k citations
Peers
Comparison fields: 5 of 148
- Oncology 1.8k
- Cancer Research 694
- Immunology 711
- Molecular Biology 2.0k
- Biotechnology 254
Countries citing papers authored by Martin R. Berger
This map shows the geographic impact of Martin R. Berger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin R. Berger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin R. Berger more than expected).
Fields of papers citing papers by Martin R. Berger
This network shows the impact of papers produced by Martin R. Berger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin R. Berger. The network helps show where Martin R. Berger may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Martin R. Berger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 7 | |
| 3 | 2024 | 7 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 1 | |
| 6 | 2021 | 37 | |
| 7 | 2018 | 9 | |
| 8 | 2016 | 15 | |
| 9 | 2013 | 7 | |
| 10 | 2012 | 9 | |
| 11 | 2011 | 30 | |
| 12 | 2008 | 37 | |
| 13 | 2007 | 19 | |
| 14 | HoxC8 in cancer: Suppressor or progressor? | 2005 | 8 |
| 15 | 1998 | 40 | |
| 16 | 1998 | 2 | |
| 17 | 1992 | 5 | |
| 18 | 1992 | 50 | |
| 19 | 1987 | 22 | |
| 20 | 1984 | 32 |
About Martin R. Berger
Martin R. Berger is a scholar working on Oncology, Cancer Research, Biotechnology, Immunology and Hepatology, having authored 245 papers that have together received 4.9k indexed citations. Recurring topics across this work include Bone and Dental Protein Studies (18 papers), Metal complexes synthesis and properties (15 papers), Colorectal Cancer Treatments and Studies (15 papers), Chemokine receptors and signaling (14 papers), Toxin Mechanisms and Immunotoxins (14 papers), Cancer therapeutics and mechanisms (14 papers), PI3K/AKT/mTOR signaling in cancer (13 papers) and Genetic factors in colorectal cancer (13 papers). The work is most often cited by research in Oncology (1.8k citations), Cancer Research (694 citations), Immunology (711 citations), Molecular Biology (2.0k citations) and Biotechnology (254 citations). Martin R. Berger has collaborated with scholars based in Germany, Bulgaria and United States. Frequent co-authors include Hassan Adwan, D. Schmähl, Spiro Konstantinov, Tobias Bäuerle, Carl C. Schimanski, Michael Zepp, Peter R. Galle, Bernhard K. Keppler, Ergül Eyol and Markus Moehler. Their work appears in journals such as Journal of Cancer Research and Clinical Oncology, Cancer Letters, International Journal of Cancer, Cancer Chemotherapy and Pharmacology and International Journal of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.